Showing results (501-510 of 9,918) with videos related to

Sort By:
Pageof 992
Bone Marrow Transplantation|May 19, 2019
A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myelomaNoa Biran, Scott D Rowley, David H Vesole, et al.
Bone Marrow Transplantation|June 1, 2019
Safety and efficacy of fresh whole blood donor lymphocyte infusion in childrenVenkateswaran Vellaichamy Swaminathan, Ramya Uppuluri, Shivani Patel, et al.
Bone Marrow Transplantation|May 16, 2019
Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalitiesRama Al Hamed, Abdul Hamid Bazarbachi, Mohamad Mohty
Bone Marrow Transplantation|May 16, 2019
Red blood cell transfusion burden by day 30 predicts mortality in adults after single-unit cord blood transplantationTakaaki Konuma, Maki Oiwa-Monna, Mai Mizusawa, et al.
Bone Marrow Transplantation|June 10, 2018
Pharmacokinetic and clinical outcomes when ideal body weight is used to dose busulfan in obese hematopoietic stem cell transplant recipientsShawn P Griffin, Sarah E Wheeler, Laura E Wiggins, et al.
Bone Marrow Transplantation|May 10, 2018
Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host diseaseMarietta Nygaard, Tonny Karlsmark, Niels Smedegaard Andersen, et al.
Bone Marrow Transplantation|August 9, 2018
Motives for joining an unrelated HSC donor registry: description, categorization, and association with donor availabilityAna Hallgarten La Casta, Bronwen E Shaw, Chloe Anthias, et al.
Bone Marrow Transplantation|August 10, 2018
Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patientsAna Zelic Kerep, Jacob Broome, Filip Pirsl, et al.
Bone Marrow Transplantation|August 16, 2018
Maximal concentration of intravenous busulfan as a determinant of veno-occlusive disease: a pharmacokinetic-pharmacodynamic analysis in 293 hematopoietic stem cell transplanted childrenMichaël Philippe, Michael Neely, Teresa Rushing, et al.
Bone Marrow Transplantation|August 16, 2018
High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host diseaseSarah Kraft, Noémie Bollinger, Benjamin Bodenmann, et al.
Pageof 992